Colorado Therapeutics
2015
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series A
LATEST DEAL TYPE
$2.57M
LATEST DEAL AMOUNT
Description
Developer of xenogenic biologic tissue matrix products. The company develops a tissue processing technology that is focused on developing xenogenic biologic tissue matrix products and therapeutic devices for a broad range of soft tissue reinforcement, regenerative and vascular applications.
Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
- 2150 West 6th Avenue
- Unit L
- Broomfield, CO 80020
- United States
+1 (303) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Colorado Therapeutics’s full profile, request a free trial.
Colorado Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 17-Apr-2017 | $2.57M | 00.000 | Completed | Startup | |
| 1. Angel (individual) | 18-Apr-2016 | 00.00 | 00.00 | Completed | Startup |
Colorado Therapeutics Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Joseph Horn | President & Chief Executive Officer | ||
| John Lorbiecki | Chief Operating Officer | ||
| Eric Schauble | Vice President, Corporate Development |
Colorado Therapeutics Board Members (2)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| James Gleeson | Colorado Therapeutics | Board Member | 000 0000 | |
| Thomas Raegan | Colorado Therapeutics | Board Member | 000 0000 |